FibroGen, Inc.FGENNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
2738.83%
↑ 4306% above average
Average (39q)
-65.12%
Historical baseline
Range
High:2738.83%
Low:-3860.00%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 2738.83% |
| Q2 2025 | -3860.00% |
| Q1 2025 | -98.89% |
| Q4 2024 | 205.88% |
| Q3 2024 | -9.25% |
| Q2 2024 | -1078.79% |
| Q1 2024 | 42.11% |
| Q4 2023 | 12.31% |
| Q3 2023 | 27.78% |
| Q2 2023 | -11.11% |
| Q1 2023 | -15.71% |
| Q4 2022 | 28.57% |
| Q3 2022 | -25.64% |
| Q2 2022 | -14.71% |
| Q1 2022 | 53.10% |
| Q4 2021 | -368.52% |
| Q3 2021 | 137.24% |
| Q2 2021 | -85.90% |
| Q1 2021 | -21.88% |
| Q4 2020 | -277.78% |
| Q3 2020 | 137.89% |
| Q2 2020 | -6.74% |
| Q1 2020 | 20.54% |
| Q4 2019 | -96.49% |
| Q3 2019 | -142.54% |
| Q2 2019 | 352.83% |
| Q1 2019 | -312.00% |
| Q4 2018 | 150.00% |
| Q3 2018 | -78.57% |
| Q2 2018 | 44.00% |
| Q1 2018 | -85.19% |
| Q4 2017 | 46.00% |
| Q3 2017 | -4.17% |
| Q2 2017 | 7.69% |
| Q1 2017 | 3.70% |
| Q4 2016 | -42.11% |
| Q3 2016 | -197.44% |
| Q2 2016 | 186.67% |
| Q1 2016 | 45.78% |
| Q4 2015 | -12.16% |